'Navigator' - An innovative approach to mobilise our FiY1 doctors during this emergency crisis.

“Navigator”——在这场紧急危机中动员我们的 FiY1 医生的创新方法。

基本信息

  • 批准号:
    54466
  • 负责人:
  • 金额:
    $ 9.52万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Feasibility Studies
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

The COVID-19 pandemic has caused the NHS workforce to be stretched beyond reasonable demands. One method of relieving this workload was for the UK Medical School Council to fast-track final year graduated medical students to qualified doctors. These newly qualified Foundation Interim Year 1 (FiY1) doctors are a valuable resource and will be completing low-risk procedures and clerking.The potential problem is effectively utilising this unprecedented FiY1 role in a way that truly alleviates the extra workload for current NHS staff. Maximising time and resources of experienced clinical staff is key to fighting this pandemic. The novelty of the FiY1 role invites inevitable uncertainty, worry and communication issues between current medical staff and FiY1 doctors. We predict this will potentially lead to an inherent inefficiency within the healthcare system that the NHS cannot afford during a pandemic (e.g. work flow, burden on supervision roles and coordination between staff). Our proposed mechanism addresses the current workload during this pandemic.Our service (Navigator) will replace the need of face-to-face coordination of new FiY1s by supervisors; in real-time, FiY1 doctors can be requested to wards by other staff members for specific duties they are competent in. This not only frees-up time for experienced staff to focus on other work but also maximises the efficiency of the FiY1 doctor. For patients, this means faster diagnosis and treatment speeding up the patient pathway and less time in hospital; for staff this means a more productive workday. We envision FiY1 doctors flowing between wards across the hospital, meeting demand in clinical settings quicker than ever before - once one task is completed the FiY1 can simply open our application and move onto the next clinical duty. To enhance their performance with this technology, we will digitalise responsibility of work through weekly work reports that can be submitted to their clinical supervisors. There is no patient data transferred and staff details are anonymized, so there are no data protection or security issues. We are facilitating the paperless NHS agenda and reducing face-to-face communication which can be complicated during a pandemic.The necessity to stream-line workflow is more vital than ever in the current healthcare climate. We have reinvented the way medical staff will liaise with FiY1 doctors during this difficult time, and we hope also doctors and students of the future. Patients will also be the beneficiaries of a more responsive NHS service.--ADDITIONAL INFORMATION HERE-- We have completed Beta Phase Testing of Navigator and the product is currently being audited and stress-tested professionally with plans for further digital certification. The Extension for Impact will allow us to complete a full comprehensive research and development assessment, meeting national guidelines for digital implementation, we estimate to be completed by January 2021. Hence, the Extension for Impact will enable us to excel the product to be officially prepared for widespread implementation across NHS England. This includes user research, communication interoperability, data security and information governance.Our business model currently stands on the framework that we are expecting through our implementation and trial license fees to gain us a revenue that we can sustain the development of the project through. Our business strategist has provided us with a blueprint of how to engage in discussions with hospital executives and shown us at length how to successfully complete the NHS tendering process. He has also provided us with access to his well-established networks, that include a range of high-profile healthcare professionals and entrepreneurs that we can engage in discussions to launch internationally, only once the product is officially licensed in a few hospitals and develops a stronghold in medical education in the UK. After this extension this will be our last phase of product development. After this will be executing national commercialisation through the business model developed within the first quarter of this project with our business strategist.
COVID-19大流行导致NHS的劳动力超出了合理的需求。减轻这种工作量的一种方法是英国医学院理事会快速跟踪最后一年毕业的医学生到合格的医生。这些新获得资格的基金会中期第1年(FiY 1)医生是一个宝贵的资源,将完成低风险的程序和办事员.潜在的问题是有效地利用这一前所未有的FiY 1的作用,真正减轻了当前NHS工作人员的额外工作量的方式.最大限度地利用经验丰富的临床工作人员的时间和资源是抗击这一流行病的关键。FiY 1角色的新奇引发了当前医务人员和FiY 1医生之间不可避免的不确定性,担忧和沟通问题。我们预测,这可能会导致医疗保健系统内在的低效率,NHS在大流行期间无法承受(例如工作流程,监督角色的负担和工作人员之间的协调)。我们建议的机制解决了当前疫情期间的工作量。我们的服务(导航器)将取代由主管面对面协调新的第一财政年度医生的需要;其他工作人员可以实时要求第一财政年度医生到病房执行他们胜任的特定职责。这不仅为经验丰富的员工腾出时间专注于其他工作,还最大限度地提高了FiY 1医生的效率。对患者来说,这意味着更快的诊断和治疗,加快患者的治疗速度,缩短住院时间;对工作人员来说,这意味着更有效率的工作日。我们设想FiY 1医生在整个医院的病房之间流动,比以往任何时候都更快地满足临床环境的需求-一旦完成一项任务,FiY 1可以简单地打开我们的应用程序并进入下一个临床任务。为了利用这项技术提高他们的表现,我们将通过每周工作报告将工作责任数字化,并提交给他们的临床主管。没有患者数据传输,工作人员的详细信息是匿名的,因此没有数据保护或安全问题。我们正在推动无纸化NHS议程,减少面对面的沟通,这在大流行期间可能会变得复杂。在当前的医疗环境下,简化工作流程的必要性比以往任何时候都更加重要。我们已经重新设计了医务人员在这个困难时期与第一财政年度医生联系的方式,我们希望未来的医生和学生也是如此。患者也将成为更敏感的NHS服务的受益者。其他信息在这里-我们已经完成了导航器的Beta阶段测试,该产品目前正在进行审计和压力测试,并计划进一步的数字认证。影响扩展将使我们能够完成全面的研究和开发评估,符合国家数字实施指南,我们预计将于2021年1月完成。因此,扩展影响将使我们能够超越产品,正式准备在NHS英格兰广泛实施。这包括用户研究、通信互操作性、数据安全和信息治理。我们的商业模式目前基于我们期望通过实施和试用许可费为我们获得收入的框架,我们可以通过这些收入来维持项目的发展。我们的业务战略家为我们提供了一个如何与医院高管进行讨论的蓝图,并详细向我们展示了如何成功完成NHS招标过程。他还为我们提供了访问他建立良好的网络,其中包括一系列知名的医疗保健专业人士和企业家,我们可以参与讨论,以便在国际上推出,只有当该产品在几家医院获得正式许可并在英国医学教育中建立据点时。在这次扩展之后,这将是我们产品开发的最后阶段。在此之后,将通过与我们的业务战略家在该项目的第一季度内开发的商业模式执行全国商业化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Studentship

相似海外基金

NSF Convergence Accelerator (L): Innovative approach to monitor methane emissions from livestock using an advanced gravimetric microsensor.
NSF Convergence Accelerator (L):使用先进的重力微传感器监测牲畜甲烷排放的创新方法。
  • 批准号:
    2344426
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Standard Grant
Health System Science: An Innovative Approach to Addressing Chronic Disease Management in Medical Education
卫生系统科学:解决医学教育中慢性病管理的创新方法
  • 批准号:
    502606
  • 财政年份:
    2024
  • 资助金额:
    $ 9.52万
  • 项目类别:
Exploring ATR and PARP Inhibitors for Ovarian Cancer Management: An Innovative Approach
探索 ATR 和 PARP 抑制剂用于卵巢癌治疗:一种创新方法
  • 批准号:
    494635
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Operating Grants
High-Throughput Functional Genomics of Variants in Genes Linked to Substance Use Disorders
与药物使用障碍相关的基因变异的高通量功能基因组学
  • 批准号:
    10728785
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
An innovative and straightforward approach to construct and manipulate viral infectious clones
构建和操作病毒感染性克隆的创新且简单的方法
  • 批准号:
    10667766
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
Biology through art: an innovative, interdisciplinary approach to teaching biology
通过艺术的生物学:一种创新的、跨学科的生物学教学方法
  • 批准号:
    2315749
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Standard Grant
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
  • 批准号:
    10736961
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
Evaluating an Innovative Approach to Understanding the Development of Walking and Care for Children with Mobility Impairments
评估了解步行发展和照顾行动障碍儿童的创新方法
  • 批准号:
    495766
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Operating Grants
Combination of tumor targeted therapy with stroma modulating agent for PDAC
肿瘤靶向治疗与基质调节剂联合治疗 PDAC
  • 批准号:
    10629924
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
Fibroblast-derived laminin regulates blood-brain barrier integrity and fibroblast biology in hemorrhagic brain
成纤维细胞衍生的层粘连蛋白调节出血脑中的血脑屏障完整性和成纤维细胞生物学
  • 批准号:
    10749280
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了